Betamethasone dipropionate NDC 50090-7525

NDC codes

FDA NDC Directory

Product NDC (as listed)50090-7525Labeler and product segments. Claims need a package NDC.

Product NDC at billing width50090-7525Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
50090-7525-0	50090752500	1 TUBE in 1 CARTON (50090-7525-0) / 45 g in 1 TUBEMarketed from Mar 28, 2025

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Betamethasone dipropionate
Generic name (nonproprietary): betamethasone dipropionate
Active ingredients: Betamethasone dipropionate — .5 mg/g
Dosage form: Cream
Route: Topical
Labeler: A-S Medication Solutions
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208885
Marketing start: Oct 10, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Corticosteroid Hormone Receptor Agonists (Mechanism)
Identifiers: Product ID 50090-7525_116de1d8-71de-4415-8684-2457715ad7bdSPL ID 116de1d8-71de-4415-8684-2457715ad7bdSPL set ID 07a35811-7298-4f25-b280-e2f9aeab9830RxCUI 238920UNII 826Y60901U
Pharmacologic class: Corticosteroid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N450090752500 followed by a unit qualifier and the quantity

Package 50090-7525-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 1, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 208885

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208885
Product	Strength	Form · route	Labeler	Product NDC
Betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	A-S Medication Solutions	50090-4680
Betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	Zydus Pharmaceuticals USA Inc.	70710-1233
Betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	Northstar Rx LLC.	16714-996
Betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	Zydus Lifesciences Limited	70771-1380
Betamethasone dipropionate	Betamethasone dipropionate .5 mg/g	CreamTopical	Redpharm Drug	67296-2275